Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |